Promega and QuantumCyte present joint poster at AMP 2024 meeting
Promega and QuantumCyte sign co-marketing agreement aimed at enhancing the workflow solutions available to clinical laboratories
13 Nov 2024This collaboration will focus on the joint promotion of the QuantumCyte QCPRECISE!™ precision tissue enrichment platform alongside manual and automated nucleic acid purification chemistry from Promega.
The QPRECISE!™ platform increases cellular nucleic acid purity from solid tissue biopsies for downstream multiomic applications.
The joint marketing initiative will leverage both companies’ expertise to develop materials demonstrating the utility of combining QCPRECISE! with Maxwell® and ReliaPrep™ extraction platforms. Service teams from both companies will also receive product training to support customers leveraging the entire workflow.
Both companies will be attending AMP 2024 Annual Meeting & Expo, Vancouver, Canada from November 19–23, to discuss workflow solutions. They will also be showcasing a poster titled: Enhanced MSI Status Determination from FFPE Tissue Sections Using an Integrated Workflow Combining QuantumCyte’s QCPRECISE!™ with Promega’s Maxwell® CSC DNA FFPE Kit.
The Maxwell® CSC system provides consistent and reliable high-quality nucleic acid extraction for use in downstream diagnostic amplification assays.
“The Maxwell® CSC system complements QuantumCyte’s QCPRECISE!™ tissue enrichment technology to deliver a high-throughput and efficient solution for labs seeking to optimize their workflow efficiency,” says Alok Sharma, Global Clinical Market Director at Promega. “Additionally, the ReliaPrep™ kits cater to labs requiring adaptable solutions for lower throughput or specialized applications.”
“The QCPRECISE!™ Scan Print Extract (SPE) platform increases cellular nucleic acid purity from solid tissue biopsies for downstream multi-omic applications,” says John Butler, Chief Scientific Officer at QuantumCyte. “Through the integration with Maxwell® CSC System and ReliaPrep™ kits, a complete workflow that produces high purity nucleic acid is now available for use in commercial, research and pharma applications.”
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Related Products
Request Quote for All Products
GoTaq® Probe qPCR Master Mix
Promega Corp.The GoTaq® Probe qPCR Master Mix is optimized for quantitative PCR assays in the hydrolysis probe detection format. It is provided as a ready-to-use, stabilized 2X formulation that includes all components for qPCR (except template, primers and probe). This master mix does not contain a reference dye; however, a separate tube of carboxy-X-rhodamine (CXR) reference dye is included with this system, allowing users to add reference dye to amplification reactions if desired. The GoTaq® Probe qPCR Master Mix is designed to provide resistance to a wide range of PCR inhibitors. This formulation uses antibody-mediated hot-start chemistry, allowing reaction setup to be performed at room temperature. The master mix also employs rapid hot-start activation and processive enzymes, making it compatible with both standard and fast instrument cycling programs. Features - Benefits • Superior Performance: Sensitive detection on any real-time instrument • Enhanced Stability: Exceptional room-temperature setup makes it suitable for automation and high-throughput detection • Versatility: Compatible with both fast and standard cycling methods • Robustness: High-efficiency, full-length cDNA synthesis in the presence of inhibitors • Confidence: The Promega PCR Performance Guarantee Applications • Sensitive sequence detection and quantification • Gene expression analysis • Detection of sequence variants • Fluorescent detection